Back to search

Aspire Pharma Holdings Limited

09306251

liquidation
Private Limited Company
Companies House
Health Score
N/A

Details

6TH FLOOR, 2, LONDON, EC2Y 5AU
Incorporated 11/11/2014

Compliance

Accounts

Up to date

Confirmation statement

Up to date

Industry

46460
Wholesale of pharmaceutical goods

Officers

Mr Mark Derek Roberts

director · Since 09/12/2014

COMPANY DIRECTOR

BRITISH · UNITED KINGDOM · Age 58

Also on 1 other board

Graham Julian Fraser-Pye

director · Since 09/12/2014

DIRECTOR

BRITISH · ENGLAND · Age 58

Ian Jacobson

director · Since 09/12/2014

CHIEF EXECUTIVE

CANADIAN · CANADA · Age 66

Jacqueline Elizabeth Fraser-Pye

secretary · Since 09/04/2018

Mr Craig Podolsky

director · Since 15/06/2020

INVESTMENT PROFESSIONAL

CANADIAN · CANADA · Age 45

Also on 1 other board

Mr Gary David Buckley

secretary · Since 15/06/2020

Also on 13 other boards

Mr Jonathan Charles May

director · Since 15/06/2020

GENERAL MANAGER

BRITISH · ENGLAND · Age 56

Also on 12 other boards

Mr Gary David Buckley

director · Since 15/06/2020

FINANCE DIRECTOR

BRITISH · ENGLAND · Age 40

Also on 13 other boards

Persons with Significant Control

Aphl 1 Limited

75–100% shares
75–100% votes

102, High Street, Godalming, GU7 1DS

Reg: 11534559 · Companies House · Limited Company

Notified 04/09/2019

Former PSCs

Mr Graham Julian Fraser-Pye

Ceased 04/09/2019

Juno Pharmaceuticals Luxembourg S.A.R.L

Ceased 04/09/2019

Charges0 outstanding

Charge
satisfied

BARCLAYS BANK PLC

Created 31/03/2017Registered 01/04/2017Satisfied 12/04/2019
Charge
satisfied

BARCLAYS BANK PLC

Created 23/12/2016Registered 05/01/2017Satisfied 05/02/2021
Charge
satisfied

GRAHAM FRASER-PYE

Created 09/12/2014Registered 23/12/2014Satisfied 04/09/2019

CompanyRankvs 15+ SIC 46460 peers
47

Financial strengthNo net worth data · 0/25
EmployeesNo employee data · 0/15
LiquidityCurrent ratio 19.13× · 20/20
Longevity12 years trading (max 15) · 12/15
Filing complianceAll filings up to date · 15/15
Show leaderboard
1Rayburn Trading Company Limited
90
2Servier Laboratories Limited
90
3P & A J Cattee (Wholesale) Ltd.
90
4Hameln Pharma Ltd
90
5Day Lewis Medical Limited
90
6Kinetic Enterprises Limited
90
7Morningside Pharmaceuticals Limited
90
8A1 Pharmaceuticals Public Limited Company
90
9Greiner Bio-One Limited
90
10Trafalgar Scientific Limited
90
How is this score calculated?
Financial strength0/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees0/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity20/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity12/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 31/12/2020

Net Worth

£2.6M

Balance sheet strength

Cash

£238k

Cash in the bank

Net Current Assets

£226k

Working capital

Current Assets

£238k

Current Liabilities

£12k

Debtors

£215

5avg. employees+1

Tax at Year End(2019)

Dividends paid-£692k

Balance Sheet

Assets less current liabilities£4.1M
Prepared with CCH Software

EstimatesDerived

YearCurrent RatioImplied Profit
202019.13-£67k
20192.67—

Derived from filed accounts. Not audited figures.